APA-Zitierstil (7. Ausg.)

Grünig, E., Rahaghi, F., Elwing, J., Vizza, C. D., Pepke-Zaba, J., Shen, J., . . . White, R. J. (2024). Oral treprostinil is associated with improved survival in FREEDOM-EV and its open-label extension. Advances in therapy, 41(2), . https://doi.org/10.1007/s12325-023-02711-x

Chicago-Zitierstil (17. Ausg.)

Grünig, Ekkehard, et al. "Oral Treprostinil Is Associated with Improved Survival in FREEDOM-EV and Its Open-label Extension." Advances in Therapy 41, no. 2 (2024). https://doi.org/10.1007/s12325-023-02711-x.

MLA-Zitierstil (9. Ausg.)

Grünig, Ekkehard, et al. "Oral Treprostinil Is Associated with Improved Survival in FREEDOM-EV and Its Open-label Extension." Advances in Therapy, vol. 41, no. 2, 2024, https://doi.org/10.1007/s12325-023-02711-x.